Skip to main content

Table 3 Adjusted mean total all-cause costs (excluding DMT costs) in year 2010 a

From: Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity

  Mean Standard error Upper level of 95% CI Lower level of 95% CI
HRA group $26,803.19 $1126.41 $24,478.92 $28,793.61
Non-HRA group $14,745.85 $211.09 $14,365.36 $15,140.86
Cost difference 12,057.34 $1149.85 $9,716.94 $14,073.66
  1. aBootstrapping: repeat 200; bias correction method.
  2. HRA=high relapse activity; CI=confidence interval.
\